Praktik kerja profesi di Rumah Sakit Umum Pusat Fatmawati Periode Januari-Februari 2018 bertujuan untuk memahami tugas dan tanggung jawab apoteker dalam pengelolaan perbekalan farmasi, serta melakukan praktik pelayanan kefarmasian sesuai dengan ketentuan perundang-undangan dan etika yang berlaku, memiliki wawasan, pengetahuan, keterampilan dan pengalaman praktis untuk melakukan praktik kefarmasian di rumah sakit, memiliki gambaran nyata tentang permasalahan praktik kefarmasian serta mempelajari strategi dan kegiatan-kegiatan yang dapat dilakukan dalam rangka pengembangan praktik kefarmasian. Praktik kerja profesi ini dilaksanakan selama enam minggu dengan tugas khusus yaitu ldquo;Pemantauan Terapi Obat pada Pasien Sindrom Koroner Akut Stemi di Ruang Isolasi Gedung Teratai Lantai 4 Selatan RSUP Fatmawati Periode 19-31 Januari 2018 rdquo;. Tujuan dari tugas khusus ini yaitu untuk mengevaluasi masalah terkait terapi obat pada pasien Ny. CBT di Ruang Isolasi Gedung Teratai Lantai 4 Selatan melalui pemantauan terapi obat dengan Pharmaceutical Care Network Europe PCNE system V8.01.

---

Internship at Fatmawati General Hospital for the Period of January - February of 2018 aims to understand the duties and responsibilities of pharmacists in pharmaceutical supplies, as well as to practice pharmaceutical services in accordance with applicable laws and ethics, have the insight, knowledge, skills and practical experience to undertake pharmaceutical practices in hospital, can also have the insight of pharmaceutical practice issues and learn strategies and activities that can be undertaken in the course of pharmaceutical practice development. This internship at was conducted for six weeks with special assignment ldquo;Monitoring of Drug Therapy in Patients Acute Coronary Syndrome in Isolation Room of Lotus Building South 4th at Fatmawati General Hospital Period 19-31 January 2018 rdquo;. The purpose of this special assignment is to evaluate patients drug related problems at the Isolation Room of Lotus Building South 4th Floor through the monitoring of drug therapy with Pharmaceutical Care Network Europe PCNE system V8.01.